Researchers have uncovered another piece of the Parkinson’s disease puzzle, identifying that particular immune cells are active long before the hallmark motor symptoms become apparent. It paves ...

Progenra Inc. reports that it has discovered a new class of small-molecule PINK1 activators that restore function in mutant forms of the PINK1 kinase, a key mitochondrial regulator whose dysfunction ...

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.  For people with autoimmune disease, T cell reactivity is a big ...

In a major scientific advance, Progenra Inc. has announced the discovery of a novel class of small-molecule drugs designed to restore the function of mutant forms of ...

Researchers reported that the AI model could accurately distinguish between individuals with and without Parkinson's based on the analysis of their smiles.

Four compounds in ear canal secretions differ between those with and without Parkinson’s disease, suggesting they may be accurate biomarkers for the disease.

Researchers in ACS’ Analytical Chemistry report the initial development of a system that inexpensively screens for Parkinson’s disease from the odors in a person’s ear wax.

Prothena announced partner Roche will advance prasinezumab into Phase III development in early-stage Parkinson’s disease.

Read this clinical update to learn how patient-reported outcomes can contribute to the research of Parkinsons.